Medicare Rates Increase Higher Than Expected
Insurers will receive a payment increase of 0.45% next year, which is higher than the expected 0.25% increase. According to The Wall Street Journal, the increase will benefit insurers offering private plans through Medicare Advantage. America’s Health Insurance Plans responded to the news with a call for more flexibility in the program, which covers 18.5 million Americans, or one-third of the total Medicare population.
Support for ACA Grows
For the first time, a majority of Americans now support the Affordable Care Act (ACA). A Gallup poll found 55% of Americans approve of the ACA, up from 42% in November 2016. TIME reported that only 26% want to keep the law unchanged, while a larger proportion (40%) want to make significant changes to the law, but don’t think the ACA should be repealed.
Opposition to Gottlieb
Today, Scott Gottlieb, MD, the nominee to head the FDA, will testify before the Senate Health, Education, Labor, and Pensions Committee at a confirmation hearing. However, 2 senators have come out as publicly opposing Gottlieb, reported The Wall Street Journal. They cite Gottlieb’s past ties with drug companies and his desire to speed up approvals, which could benefit those companies he has received money from in the past. Gottlieb has said he will divest himself of financial interests that raise ethical concerns and recuse himself from decisions involving more than 20 companies.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More